BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11818304)

  • 1. Recognition of osteoporosis by primary care physicians.
    Gehlbach SH; Fournier M; Bigelow C
    Am J Public Health; 2002 Feb; 92(2):271-3. PubMed ID: 11818304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of pharmacotherapy and counseling for osteoporosis management in visits to US ambulatory care physicians by women.
    Lee E; Zuckerman IH; Weiss SR
    Arch Intern Med; 2002 Nov; 162(20):2362-6. PubMed ID: 12418951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
    Silverman SL; Delmas PD; Kulkarni PM; Stock JL; Wong M; Plouffe L
    J Am Geriatr Soc; 2004 Sep; 52(9):1543-8. PubMed ID: 15341559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of vertebral fracture in a clinical setting.
    Gehlbach SH; Bigelow C; Heimisdottir M; May S; Walker M; Kirkwood JR
    Osteoporos Int; 2000; 11(7):577-82. PubMed ID: 11069191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of osteoporosis in women aged 50 and older with osteoporosis-related fractures in a managed care population.
    Gunter MJ; Beaton SJ; Brenneman SK; Chen YT; Abbott TA; Gleeson JM
    Dis Manag; 2003; 6(2):83-91. PubMed ID: 14577902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice.
    Gudbjornsson B; Juliusson UI; Gudjonsson FV
    Ann Rheum Dis; 2002 Jan; 61(1):32-6. PubMed ID: 11779755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New spine and non-spine fractures in 871 women/year treated with oral pamidronate plus calcium and vitamin D supplements].
    Man Z; Otero AB
    Medicina (B Aires); 1997; 57 Suppl 1():32-6. PubMed ID: 9567352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing osteoporosis-related fractures: an overview.
    Gass M; Dawson-Hughes B
    Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis treatment in postmenopausal women after peripheral fractures: impact of information to general practitioners.
    Malochet-Guinamand S; Chalard N; Billault C; Breuil N; Ristori JM; Schmidt J
    Joint Bone Spine; 2005 Dec; 72(6):562-6. PubMed ID: 15996502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study.
    Weiss TW; Siris ES; Barrett-Connor E; Miller PD; McHorney CA
    Osteoporos Int; 2007 Nov; 18(11):1473-80. PubMed ID: 17577594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint.
    Marcus R; Wong M; Heath H; Stock JL
    Endocr Rev; 2002 Feb; 23(1):16-37. PubMed ID: 11844743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing fractures in postmenopausal women with osteoporosis. A review of recent controlled trials of antiresorptive agents.
    Hochberg M
    Drugs Aging; 2000 Oct; 17(4):317-30. PubMed ID: 11087009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study.
    Lukert B; Satram-Hoang S; Wade S; Anthony M; Gao G; Downs R
    Drugs Aging; 2011 Sep; 28(9):713-27. PubMed ID: 21913737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevention of osteoporosis.
    Levin RM
    Hosp Pract (Off Ed); 1991 May; 26(5):77-80, 83-6, 91-4 passim. PubMed ID: 1827635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
    Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Practice. Postmenopausal Osteoporosis.
    Black DM; Rosen CJ
    N Engl J Med; 2016 Jan; 374(3):254-62. PubMed ID: 26789873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.